All the concepts reported in this editorial are based on recent literature data obtained through a PubMed search, using both Medline and manual searches, with particular reference to articles, which could be relevant to clinical practice. This paper contributes to the existing literature on depression and stress and provides important information for the development of effective strategies to manage these conditions among patients with cancer.
Stress has received a number of definitions in scientific literature, more or less accurate or complete. One of the most commonly accepted psychological definitions has been that stress occurs when demands from the environment challenge an individual's adaptive capacity and has been associated with immune system dysfunctions. Distress is a common variable in oncologic studies and is a multifactorial, unpleasant experience of an emotional, psychological, social or spiritual nature that interferes with the ability to cope with cancer. Psychological distress can worsen physical manifestation of cancer (I).
Stress and depression-can influence tumor progression at a cellular level and several authors demonstrated in their articles the inter-relationships between stress, immune reactivity and tumor development (2) . Once a cancer patient is affected by stress, specific pathways within the brain lead to the activation of the hypothalamic-pituitary-adrenal axis as well as the central sympathetic nervous system (3) . The stress response consists in releasing key peripheral mediators such as catecholamines and glucocorticoids the role of which in the pathophysiology of chronic stress is extraordinarily complex and controversial (4) . Moreover, in cancer, catecholamines can enhance carcinogenic properties of prostate, ovary, breast and colon tumor cells (5), while glucocorticoids are immune-suppressive agents (6) . It has been reported that the immune system plays an important role in the development of cancer (7) (8) (9) . Different immune factors, such as immune cells and various interleukins, have a significant influence on the process of tumor development and appearance of metastases (10-11). On the other hand, many studies have confirmed the influence of psychological factors on different aspects of the immune system, important in the process of tumor development (12) . Cellular-mediated and humoral-mediated responses are affected in general psychiatry traumatic disorders, as is the production of cytokines (13) (14) (15) . The hypothalamic-pituitaryadrenal axis responds to several compounds, such as inflammatory cytokines: tumor necrosis factor (TNF)-u, interleukin-I (lL-I) alpha and beta, interleukin-18, interleukin-33 and interleukin-6 (16) (17) (18) (19) (20) (21) (22) . Several studies proved the correlation between stress and progression of various types of cancer and cancer recurrence, in humans (23) (24) (25) . In recent years, a number of studies have established an increasingly clear link between psychosocial or psychophysical stress, personality types and the development of cancer (26) (27) (28) . Several performed clinical trials indicated a positive correlation between psychosocial stress and the severity ofcancer and the high prevalence of psychiatric disorders in cancer patients is well known (29) . Mental disorders, such as bio-psychosocial phenomenon and quality of life in cancer diseases, assume a specific role within the therapeutic choice (30) . Physicians must give attention to the possibility of the patient's identity crises. The reconstruction of patient psycho-physical identity regarding cancer is particularly difficult. Psychological assistance acquires a relevant role in improving the patient's quality of life (31) (32) . In patients affected by cancer the body should be considered not only in the physical aspect but also as an expression of subjectivity and totality of the person.
Depressive disorders have frequently been encountered in cancer patients, and depressive elements have a tremendous impact on the quality of life, tolerance and compliance with anticancer treatment. Depressive disorders in cancer might be more relevant with practical clinical implications and are a major concern for cancer survivors. Therefore, clinicians and other health care providers should be aware of depression and communicate effectively with cancer patients and survivors about depression. Optimal care of these mood disorders have to be implemented and be supported by the association of pharmacological treatment and psychotherapy. It has been reported that the psychological and medical care needs of patients with tumor and an adequate structure for their cancer care have.so far been only marginally considered (33) . Psychotherapeutic approach is being used by patients with cancer to manage a spectrum of treatment-related symptoms and facilitate the process of psychological readjustment to the change.
There has been a great improvement in overall lifetime survival and much greater patient interest and appreciation with better follow-up and maintenance, so that we can quickly and effectively help when problems arise. Now that we have achieved an increased longevity for cancer patients, we must be able to assure them the best possible quality of life. Significant differences between medical care, psychosocial stress and the desired support were also reported in many publications (34) (35) (36) . Common psychosocial difficulties experienced by cancer patients are stress, fatigue, depression, anxiety, and existential and relational concerns (37) (38) . Psychological therapy is one intervention being developed to address these difficulties.
The purpose of this editorial is to assess and synthesize the available research evidence for the use of psychological therapy in the management of symptoms in adults with cancer. Psychological therapy is an approach that is being used by adults with cancer to manage a spectrum of treatmentrelated symptoms and facilitate the process of psychological readjustment to the loss, change, and uncertainty characteristic of cancer survivorship (39) (40) (41) (42) (43) (44) (45) . With advances in early diagnosis, treatment, and long-term management of cancer, the number of people living with metastatic and advanced cancers has continued to grow worldwide.
Since depression is common among patients with cancer, routine screening and prevention of depression are warranted among these people. However, depression occurs in a high percentage of cancer patients within 6 months of diagnosis, and it is correlated with the relationship between socioeconomic and clinical factors, age and quality of life. Psychological screening of patients with cancer is widely recommended as standard practice; however, standard screening measures may have limited sensitivity and specificity as demonstrated by the data reported in the literature. Development ofa brief screening tool that incorporates empirically supported risk factors is recommended to improve the timely identification and support ofthose patients most susceptible to adverse psychological outcomes. Efficacy of psychotherapies, in cancer patients, is supported by numerous studies (46) (47) (48) (49) (50) (51) . However, there are currently no randomized controlled trials assessing the efficacy of psychosocial intervention in the treatment of traumatic stress disorders in cancer patients. Therefore, concepts expressed here are sources extracted from the general literature found on PubMed.
These studies suggest that stress-related psychosocial factors have an adverse effect on cancer incidence and survival, although there is evidence that the results and ideas expressed in this article should be interpreted with caution. The effects that psychosocial stress exerted on immune suppression in patients with malignant cancer are well established; however, its exact effects are still unclear. In addition, further investigations are necessary and have to be implemented to clarify the efficacy and inter-relationship between psychological therapy and stressed cancer patients. Therefore, more research in this field is needed.
